Suppr超能文献

口服给药后人体中利福平的血浆和唾液浓度。

Plasma and saliva concentrations of rifampicin in man after oral administration.

作者信息

Orisakwe O E, Ofoefule S I

机构信息

Department of Pharmacology, College of Health Sciences, Nnamdi Azikiwe University, Nnew, Nigeria.

出版信息

Tokai J Exp Clin Med. 1996 Feb;21(1):45-9.

PMID:9239804
Abstract

The saliva and plasma concentrations of rifampicin were determined following oral administration of 600 mg of the drug to healthy human subjects. Rifampicin is a zwitterion with PKa's of 1.7 and 7.9. The saliva-plasma concentration ratios calculated on the basis of the PKa of 1.7 was 1.6346. The saliva concentrations were much higher than the MICs of a variety of organisms, indicating the possible usefulness of rifampicin in the treatment of susceptible oropharyngeal and nasopharyngeal pathogens. After 24 hrs, when rifampicin was completely absent in the urine, the saliva and plasma concentrations also had fallen almost to zero.

摘要

在向健康人体受试者口服600毫克利福平后,测定了其唾液和血浆中的利福平浓度。利福平是一种两性离子,其pKa值分别为1.7和7.9。根据1.7的pKa计算得出的唾液-血浆浓度比为1.6346。唾液浓度远高于多种生物体的最低抑菌浓度,这表明利福平在治疗易感口咽和鼻咽病原体方面可能有用。24小时后,尿液中完全没有利福平,此时唾液和血浆浓度也几乎降至零。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验